Published in Medical Letter on the CDC and FDA, April 2nd, 2006
According to his article, "There are several new types of vaccines that have become potential candidates for the prevention of tuberculosis. While these have been tested in the conventional animal models, less emphasis has been placed as yet on the development of safety testing procedures."
"This is particularly important if we are ever going to use such vaccines in a therapeutic or post-exposure mode, in which the risk of severe 'Koch-like' reactions may be high," said Ian...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.